Literature DB >> 32582395

Reduction of Salivary Gland Damage During Radioiodine Therapy for Differentiated Thyroid Cancers.

Byeong-Cheol Ahn1.   

Abstract

Entities:  

Year:  2020        PMID: 32582395      PMCID: PMC7295885          DOI: 10.1007/s13139-020-00643-w

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


× No keyword cloud information.
  11 in total

Review 1.  Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Gary L Francis; Steven G Waguespack; Andrew J Bauer; Peter Angelos; Salvatore Benvenga; Janete M Cerutti; Catherine A Dinauer; Jill Hamilton; Ian D Hay; Markus Luster; Marguerite T Parisi; Marianna Rachmiel; Geoffrey B Thompson; Shunichi Yamashita
Journal:  Thyroid       Date:  2015-07       Impact factor: 6.568

2.  Emptying effect of massage on parotid gland radioiodine content.

Authors:  Chae Moon Hong; Seung Hyun Son; Choon-Young Kim; Do-Hoon Kim; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  Nucl Med Commun       Date:  2014-11       Impact factor: 1.690

3.  The Preventive Effect of Parotid Gland Massage on Salivary Gland Dysfunction During High-Dose Radioactive Iodine Therapy for Differentiated Thyroid Cancer: A Randomized Clinical Trial.

Authors:  Seung Hyun Son; Chang-Hee Lee; Ji-Hoon Jung; Do-Hoon Kim; Chae Moon Hong; Ju Hye Jeong; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  Clin Nucl Med       Date:  2019-08       Impact factor: 7.794

4.  Effect of parotid gland massage on parotid gland Tc-99m pertechnetate uptake.

Authors:  Hae Won Kim; Byeong-Cheol Ahn; Sang-Woo Lee; Jaetae Lee
Journal:  Thyroid       Date:  2012-04-23       Impact factor: 6.568

Review 5.  American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.

Authors:  Bryan R Haugen; Anna M Sawka; Erik K Alexander; Keith C Bible; Patrizio Caturegli; Gerard M Doherty; Susan J Mandel; John C Morris; Aziza Nassar; Furio Pacini; Martin Schlumberger; Kathryn Schuff; Steven I Sherman; Hilary Somerset; Julie Ann Sosa; David L Steward; Leonard Wartofsky; Michelle D Williams
Journal:  Thyroid       Date:  2017-02-21       Impact factor: 6.568

6.  Iodine kinetics and dosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer.

Authors:  B Liu; R Huang; A Kuang; Z Zhao; Y Zeng; J Wang; R Tian
Journal:  Med Phys       Date:  2011-10       Impact factor: 4.071

7.  Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.

Authors:  Shin Young Jeong; Hae Won Kim; Sang-Woo Lee; Byeong-Cheol Ahn; Jaetae Lee
Journal:  Thyroid       Date:  2013-04-18       Impact factor: 6.568

Review 8.  Factors Associated with Dose Determination of Radioactive Iodine Therapy for Differentiated Thyroid Cancer.

Authors:  Chae Moon Hong; Byeong-Cheol Ahn
Journal:  Nucl Med Mol Imaging       Date:  2018-05-02

9.  Sodium iodide symporter for nuclear molecular imaging and gene therapy: from bedside to bench and back.

Authors:  Byeong-Cheol Ahn
Journal:  Theranostics       Date:  2012-04-11       Impact factor: 11.556

Review 10.  Seeking Optimal Management for Radioactive Iodine Therapy-induced Adverse Effects.

Authors:  Andreas Charalambous
Journal:  Asia Pac J Oncol Nurs       Date:  2017 Oct-Dec
View more
  1 in total

Review 1.  KSNM60 in Nuclear Endocrinology: from the Beginning to the Future.

Authors:  Chae Moon Hong; Young Jin Jeong; Hae Won Kim; Byeong-Cheol Ahn
Journal:  Nucl Med Mol Imaging       Date:  2022-01-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.